Today’s pick also ties in with Uptick’s top 5 stocks for 2016.

PBIO: PressureBiosciences

They had some great news today. The company  “exceeded its $5 million fundraising goal and approved the opening of an additional $1.25 million over-subscription amount in its PIPE offering. With growing revenue, a new multi-national partner (see below), and a potential up-listing in the near future, accredited investors have been flocking into the company’s stock through the private offering, and retail investors have been flocking into the company’s stock in the open market. Both of these may be bullish signs for individual investors for the coming year.”

Read more here: https://upticknewswire.com/investors-flock-to-pressure-biosciences-as-its-patented-pct-platform-goes-mainstream/

Uptick encourages investors to do their own due diligence in determining investment strategies that work for them. Uptick opinion is based upon individual company and market factors. Invest at your own risk.